Dyne Therapeutics Inc (DYN)
26.02
+0.06
(+0.23%)
USD |
NASDAQ |
May 10, 16:00
26.02
0.00 (0.00%)
After-Hours: 19:59
Dyne Therapeutics Shareholders Equity (Quarterly): 478.06M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 478.06M |
December 31, 2023 | 91.29M |
September 30, 2023 | 152.04M |
June 30, 2023 | 206.88M |
March 31, 2023 | 241.94M |
December 31, 2022 | 252.36M |
September 30, 2022 | 249.74M |
June 30, 2022 | 287.06M |
March 31, 2022 | 336.46M |
Date | Value |
---|---|
December 31, 2021 | 368.20M |
September 30, 2021 | 414.12M |
June 30, 2021 | 452.60M |
March 31, 2021 | 478.26M |
December 31, 2020 | 342.37M |
September 30, 2020 | 366.84M |
June 30, 2020 | 132.48M |
December 31, 2019 | 14.04M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
14.04M
Minimum
Dec 2019
478.26M
Maximum
Mar 2021
286.16M
Average
287.06M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
Solid Biosciences Inc | 126.48M |
Sana Biotechnology Inc | 375.14M |
Tenaya Therapeutics Inc | 139.42M |
Prime Medicine Inc | 133.07M |
CEL-SCI Corp | 12.65M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 522.28M |
Total Liabilities (Quarterly) | 44.22M |